🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled phase III study to e...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Hospital
Start Date
2023-05-01
Trial ID
NCT05798819
Treatments Being Tested
This is a prospective, single arm, phase II clinical study to evaluate the ...
Status
Recruiting
Location
Hongxi Zhao
Start Date
2023-10-09
Trial ID
NCT06055738
Treatments Being Tested
Patients with recurrent or metastatic cervical cancer，and will be treated w...
Status
Unknown
Location
Fudan University Shanghai Cancer Hospital
Start Date
2019-05-15
Trial ID
NCT03972722
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of GLS-010 ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09
Trial ID
NCT05518318
Treatments Being Tested
To investigate the safety and tolerability of GLS-010 in subjects with adva...
Status
Completed
Location
Peking University Cancer Hospital & Institute
Start Date
2017-07-01
Trial ID
NCT03713905
Treatments Being Tested
This is a multicenter, single-arm, open-labal, phase II clinical study with...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2022-08-01
Trial ID
NCT05540483
Treatments Being Tested
Patients with refractory cHL. Patients will be treated with GLS-010...
Status
Unknown
Location
Guizhou Cancer Hospital
Start Date
2018-08-24
Trial ID
NCT03655483
Treatments Being Tested
This is a multicenter, open-label single-arm phase II study to evaluate the...
Status
Unknown
Location
Department of Medical Oncology, Sun Yat-Sen University Cancer Center
Start Date
2023-06-14
Trial ID
NCT05900765
Treatments Being Tested
This is a multicenter, open Phase I/II study. The trial consists of two par...
Status
Unknown
Location
Shang Hai Pulmonary Hospital
Start Date
2023-08-10
Trial ID
NCT05978401
This phase I/II study tests how well zimberelimab and quemliclustat work in...
Status
Recruiting
Location
Yonemoto,Lisa
Start Date
2023-03-07
Trial ID
NCT05688215